The global antihelminthics market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). An anthelmintic is a drug that is used to treat parasitic worm infections in animals. The growing number of infected patients across the globe contributes to the growth of the anthelmintic drugs market. The rise in the prevalence of helminthic infections is also fueling market growth. The increase in pet ownership has the potential to drive significant market growth. Increased government initiatives may also aid market growth. Furthermore, increased awareness of soil-transmitted infections and filarial infections may aid in the expansion of the anthelmintic drugs market.
A full report of Wooden Decking Market is available at:https://orionmarketreports.com/global-antihelminthics-market/92814/
The demand for medical supplies is increasing in order to care for the infected population. Moreover, COVID-19 has resulted in a significant increase in demand for medical supplies such as personal protective equipment such as masks, gloves, and protective eyeglasses. With an increase in the number of COVID-19 cases worldwide, the demand for medical supplies among both healthcare professionals and civil populations for precautionary measures continues to rise. Producers of these products have an opportunity to capitalise on the increased demand for medical supplies in order to ensure an adequate and consistent supply of personal protective equipment in the market. COVID-19 is expected to have a significant impact on the anthelmintic drug market as a result of these factors.For instance, in April 2019, after receiving approval from the World Health Organization, Janssen Pharmaceutical Inc. developed Vermox (Mebendazole).
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Application
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape- Amneal pharmaceuticals LLC. Bayer AG., BoehringerIngelheim International GmbH., Cipla Inc., GlaxoSmithKline plc., Janssen Pharmaceuticals, Inc., Merck & Co., Inc. Novartis AG, Sun Pharmaceutical Industries Ltd.,among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Antihelminthics Market Report by Segment
By Type
- Benzimidazoles
- Abamectin
- Salicylanilides
- Praziquantel
- Other
By Application
- Schistosomiasis
- Fasciolasis
- Filariasis
- Angiostrongylosis
- Ascariasis
- Giardiasis
- Other
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
